Papillary proliferation of the endometrium: A clinicopathologic study of 59 cases of simple and complex papillae without cytologic atypia

American Journal of Surgical Pathology

Volumn 37, Issue 2, 2013, Pages 167-177

  Ip, Philip P C ^a   Irving, Julie A ^b   Glenn McCluggage, W ^c   Clement, Philip B ^d   Young, Robert H ^e  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b ROYAL JUBILEE HOSPITAL   (Canada)

^c ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

^d VANCOUVER GENERAL HOSPITAL   (Canada)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

endometrial carcinoma; endometrial polyp; Lehman and Hart; mucinous hyperplasia; papillary carcinoma; papillary endometrial hyperplasia; papillary proliferation

Indexed keywords

ADULT; AGED; ARTICLE; BIOPSY; CELL PROLIFERATION; CLASSIFICATION; ENDOMETRIOID CARCINOMA; ENDOMETRIUM; ENDOMETRIUM HYPERPLASIA; ENDOMETRIUM TUMOR; FEMALE; HUMAN; HYSTERECTOMY; METAPLASIA; MIDDLE AGED; PATHOLOGY; POLYP; POSTMENOPAUSE;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA, ENDOMETRIOID; CELL PROLIFERATION; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; HYSTERECTOMY; METAPLASIA; MIDDLE AGED; POLYPS; POSTMENOPAUSE; YOUNG ADULT;

EID: 84872875113     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e318272d428     Document Type: Article

References (52)

1. Silverberg SG, Kurman RJ. Tumors of the uterine corpus and gestational trophoblastic disease. In: Rosai J, Sobin LH, eds. Atlas of Tumor Pathology. Washington DC: Armed Forces Institute of Pathology; 1992;204.
2. Kurman RJ, Norris HJ. Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma. Cancer. 1982;49:2547-2559.
3. Longacre TA, Chung MH, Jensen DN, et al. Proposed criteria for the diagnosis of well-differentiated endometrial carcinoma. A diagnostic test for myoinvasion. Am J Surg Pathol. 1995;19:371-406.
4. Miliaras D, Saravelos H, Miliaras S, et al. Papillary metaplasia and decidualisation of the endometrium in a woman receiving tamoxifen and megoestrol acetate. J Obstet Gynaecol. 1997;17:309-310.
5. Lehman MB, Hart WR. Simple and complex hyperplastic papillary proliferations of the endometrium: a clinicopathologic study of nine cases of apparently localized papillary lesions with fibrovascular stromal cores and epithelial metaplasia. Am J Surg Pathol. 2001;25:1347-1354.
6. McCluggage WG. Benign diseases of the endometrium. In: Ellenson LH, Ronnett BM, Kurman RJ, eds. Blaustein's Pathology of the Female Genital Tract. New York: Springer; 2011:305-358.
7. Longacre TA, Atkins KA, Kempson RL, et al. The uterine corpus. In: Mills SE, Carter D, Greenson JK, et al, eds. Sternberg's Diagnostic Surgical Pathology. Baltimore: Lippincott Williams & Wilkins; 2010:2184-2277.
8. Ellenson LH, Ronnett BM, Kurman RJ. Precursor lesions of endometrial carcinoma. In: Ellenson LH, Ronnett BM, Kurman RJ, eds. Blaustein's Pathology of the Female Genital Tract. New York: Springer; 2011:360-391.
9. Rosai J. Female reproductive system-uterus: corpus. In: Rosai J, ed. Rosai and Ackerman's Surgical Pathology. London: Mosby Elsevier; 2011:1477-1540.
10. Silverberg SG, Kurman RJ, Norris HJ, et al. Tumours of the uterine corpus. In: Tavassoli FA, Devilee P, eds. Pathology and Genetics: World Health Organization Classification of Tumours: Tumours of the Breast and Female Genital Organs. Lyon: International Agency for Research on Cancer Press; 2003:221-232.
11. Mutter GL. Endometrial intraepithelial neoplasia (EIN): will it bring order to chaos? The Endometrial Collaborative Group. Gynecol Oncol. 2000;76:287-290.
12. Hendrickson MR, Kempson RL. The Uterine Corpus. In: Sternberg SS, ed. Diagnostic Surgical Pathology. New York: Raven Press; 1989:1591-1654.
13. McCluggage WG. Miscellaneous disorders involving the endometrium. Semin Diagn Pathol. 2010;27:287-310.
14. Clement PB, Young RH. Endometrioid carcinoma of the uterine corpus: a review of its pathology with emphasis on recent advances and problematic aspects. Adv Anat Pathol. 2002;9:145-184.
15. Hendrickson MR, Kempson RL. The uterine corpus. In: Sternberg SS, ed. Diagnostic Surgical Pathology. New York: Raven Press; 1994:2091-2193.
16. Mills AM, Longacre TA. Endometrial hyperplasia. Semin Diagn Pathol. 2010;27:199-214.
17. Karim RZ, Russell P. Test and teach. Diagnosis: benign metaplastic papillary change in an endometrial polyp. Pathology. 2003;35: 522-525.
18. Hendrickson MR, Kempson RL. Endometrial hyperplasia, metaplasia and carcinoma. In: Fox H, ed. Haines and Taylor Obstetrics and Gynaecological Pathology. New York: Churchhill Livingstone; 1987:354-404.
19. Wheeler DT, Bristow RE, Kurman RJ. Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins. Am J Surg Pathol. 2007;31:988-998.
20. Jacques SM, Qureshi F, Lawrence WD. Surface epithelial changes in endometrial adenocarcinoma: diagnostic pitfalls in curettage specimens. Int J Gynecol Pathol. 1995;14:191-197.
21. Savelli L, De Iaco P, Santini D, et al. Histopathologic features and risk factors for benignity, hyperplasia, and cancer in endometrial polyps. Am J Obstet Gynecol. 2003;188:927-931.
22. Bakour SH, Khan KS, Gupta JK. The risk of premalignant and malignant pathology in endometrial polyps. Acta Obstet Gynecol Scand. 2000;79:317-320.
23. Perri T, Rahimi K, Ramanakumar AV, et al. Are endometrial polyps true cancer precursors? Am J Obstet Gynecol. 2010;203:e231-e236.
24. Kennedy MM, Baigrie CF, Manek S. Tamoxifen and the endometrium: review of 102 cases and comparison with HRTrelated and non-HRT-related endometrial pathology. Int J Gynecol Pathol. 1999;18:130-137.
25. Schlesinger C, Kamoi S, Ascher SM, et al. Endometrial polyps: a comparison study of patients receiving tamoxifen with two control groups. Int J Gynecol Pathol. 1998;17:302-311.
26. Feeley KM, Wells M. Hormone replacement therapy and the endometrium. J Clin Pathol. 2001;54:435-440.
27. Fukunaga M, Ushigome S. Epithelial metaplastic changes in ovarian endometriosis. Mod Pathol. 1998;11:784-788.
28. Clement PB. The pathology of endometriosis: a survey of the many faces of a common disease emphasizing diagnostic pitfalls and unusual and newly appreciated aspects. Adv Anat Pathol. 2007;14:241-260.
29. McCluggage WG. Mullerian adenosarcoma of the female genital tract. Adv Anat Pathol. 2010;17:122-129.
30. Hendrickson MR, Kempson RL. Endometrial epithelial metaplasias: proliferations frequently misdiagnosed as adenocarcinoma. Report of 89 cases and proposed classification. Am J Surg Pathol. 1980;4:525-542.
31. Nucci MR, Prasad CJ, Crum CP, et al. Mucinous endometrial epithelial proliferations: a morphologic spectrum of changes with diverse clinical significance. Mod Pathol. 1999;12:1137-1142.
32. Vang R, Tavassoli FA. Proliferative mucinous lesions of the endometrium: analysis of existing criteria for diagnosing carcinoma in biopsies and curettings. Int J Surg Pathol. 2003;11:261-270.
33. Nicolae A, Preda O, Nogales FF. Endometrial metaplasias and reactive changes: a spectrum of altered differentiation. J Clin Pathol. 2011;64:97-106.
34. He M, Jackson CL, Breese V, et al. K-ras mutations in mucinous lesions of uterus [abstract]. Mod Pathol. 2012;25:276A.
35. Yoo SH, Park BH, Choi J, et al. Papillary mucinous metaplasia of the endometrium as a possible precursor of endometrial mucinous adenocarcinoma. Mod Pathol. 2012;25:1496-1507.
36. Lax SF, Kendall B, Tashiro H, et al. The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways. Cancer. 2000;88:814-824.
37. Duggan BD, Felix JC, Muderspach LI, et al. Microsatellite instability in sporadic endometrial carcinoma. J Natl Cancer Inst. 1994;86:1216-1221.
38. Duggan BD, Felix JC, Muderspach LI, et al. Early mutational activation of the c-Ki-ras oncogene in endometrial carcinoma. Cancer Res. 1994;54:1604-1607.
39. Esteller M, Garcia A, Martinez-Palones JM, et al. Clinicopathologic features and genetic alterations in endometrioid carcinoma of the uterus with villoglandular differentiation. Am J Clin Pathol. 1999;111:336-342.
40. Levine RL, Cargile CB, Blazes MS, et al. PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma. Cancer Res. 1998;58:3254-3258.
41. Sun H, Enomoto T, Shroyer KR, et al. Clonal analysis and mutations in the PTEN and the K-ras genes in endometrial hyperplasia. Diagn Mol Pathol. 2002;11:204-211.
42. Zaino RJ, Kurman RJ, Brunetto VL, et al. Villoglandular adenocarcinoma of the endometrium: a clinicopathologic study of 61 cases: a gynecologic oncology group study. Am J Surg Pathol. 1998;22:1379-1385.
43. Murray SK, Young RH, Scully RE. Uterine endometrioid carcinoma with small nonvillous papillae: an analysis of 26 cases of a favorable-prognosis tumor to be distinguished from serous carcinoma. Int J Surg Pathol. 2000;8:279-289.
44. Ross JC, Eifel PJ, Cox RS, et al. Primary mucinous adenocarcinoma of the endometrium. A clinicopathologic and histochemical study. Am J Surg Pathol. 1983;7:715-729.
45. Fujiwara M, Longacre TA. Low-grade mucinous adenocarcinoma of the uterine corpus: a rare and deceptively bland form of endometrial carcinoma. Am J Surg Pathol. 2011;35:537-544.
46. McCluggage WG, Connolly LE, McBride HA, et al. HMGA2 is commonly expressed in uterine serous carcinomas and is a useful adjunct to diagnosis. Histopathology. 2012;60:547-553.
47. McCluggage WG, McBride HA. Papillary syncytial metaplasia associated with endometrial breakdown exhibits an immunophenotype that overlaps with uterine serous carcinoma. Int J Gynecol Pathol. 2012;31:206-210.
48. McCluggage WG, Soslow RA, Gilks CB. Patterns of p53 immunoreactivity in endometrial carcinomas: 'all or nothing' staining is of importance. Histopathology. 2011;59:786-788.
49. Kurman RJ, Scully RE. Clear cell carcinoma of the endometrium: an analysis of 21 cases. Cancer. 1976;37:872-882.
50. Zaman SS, Mazur MT. Endometrial papillary syncytial change. A nonspecific alteration associated with active breakdown. Am J Clin Pathol. 1993;99:741-745.
51. Shah SS, Mazur MT. Endometrial eosinophilic syncytial change related to breakdown: immunohistochemical evidence suggests a regressive process. Int J Gynecol Pathol. 2008;27:534-538.
52. Clement PB, Young RH. Nonneoplastic lesions of the uterine corpus. Atlas of Gynecologic Surgical Pathology. Philadelphia: W.B. Saunders; 2008:139-160.